Role of Insulin Resistance in Increased Frequency of Atherosclerosis Detected by Carotid Ultrasonography in Rheumatoid Arthritis
Overview
Authors
Affiliations
Objective: We evaluated the presence of subclinical atherosclerosis and factors influencing atherosclerosis, including insulin resistance (IR), in patients with rheumatoid arthritis (RA).
Methods: Sixty-three patients with RA and 34 controls were studied. Patients' cardiovascular risk factors were recorded; biochemical variables were determined. Intima-media thickness (IMT) of carotid arteries was determined by B-mode ultrasonography, and presence of atheromatous plaques was determined. IR was calculated according to the HOMA-IR homeostasis model.
Results: There were no differences in atherosclerotic risk factors between patients with RA and controls. In the RA group, the median carotid IMT was 0.61 mm (range 0.56-0.74), greater than the 0.54 mm (range 0.50-0.64) in controls (p = 0.01). There was a tendency to a higher frequency of carotid plaques in the RA group compared to controls [12 RA patients (19%) vs 2 controls (5.9%); p = 0.10]. Multivariate regression analysis revealed the factors that had an independent effect on increased carotid IMT: age (p < 0.001), male sex (p = 0.01), and total cholesterol level (p = 0.02). In RA patients with plaques, age (64.5 vs 48 yrs; p = 0.005), carotid IMT (0.75 vs 0.60 mm; p = 0.001), frequency of hypertension (58.3% vs 23.5%; p = 0.03), and IR (83.3% vs 29.4%; p = 0.001) were higher. Multivariate logistic regression analysis showed that factors independently associated with the presence of plaques were IR (OR 15.85, 95% CI 2.23-112.89, p = 0.006) and age (OR 1.11, 95% CI 1.02-1.21, p = 0.02). In RA patients, HOMA-IR correlated with age (r = 0.26, p = 0.04), Health Assessment Questionnaire score (r = 0.28, p = 0.04), and concentrations of triglyceride (r = 0.39, p = 0.003) and cholesterol (r = 0.33, p = 0.02).
Conclusion: IR in the setting of active rheumatoid disease may contribute to mechanisms of accelerated atherogenesis observed in patients with RA.
Jamthikar A, Gupta D, Puvvula A, Johri A, Khanna N, Saba L Rheumatol Int. 2020; 40(12):1921-1939.
PMID: 32857281 PMC: 7453675. DOI: 10.1007/s00296-020-04691-5.
Guin A, Sinhamahapatra P, Misra S, Choudhury Mazumder S, Chatterjee S, Ghosh A Biomed J. 2020; 42(6):394-402.
PMID: 31948603 PMC: 6962725. DOI: 10.1016/j.bj.2019.01.007.
Comorbidities in polymyalgia rheumatica: a systematic review.
Partington R, Helliwell T, Muller S, Abdul Sultan A, Mallen C Arthritis Res Ther. 2018; 20(1):258.
PMID: 30458857 PMC: 6247740. DOI: 10.1186/s13075-018-1757-y.
Incretins in patients with rheumatoid arthritis.
Tejera-Segura B, Lopez-Mejias R, Dominguez-Luis M, de Vera-Gonzalez A, Gonzalez-Delgado A, Ubilla B Arthritis Res Ther. 2017; 19(1):229.
PMID: 29041949 PMC: 5645916. DOI: 10.1186/s13075-017-1431-9.
Abnormal Glucose Metabolism in Rheumatoid Arthritis.
Pi H, Zhou H, Jin H, Ning Y, Wang Y Biomed Res Int. 2017; 2017:9670434.
PMID: 28529957 PMC: 5424188. DOI: 10.1155/2017/9670434.